TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Clinical trial NCT03959241 · COMPLETED

Trial details

NCT number: NCT03959241
Sponsor: Medical College of Wisconsin
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Leukemia Chronic Myelogenous Leukemia (CML)Myelodysplasia Lymphoma

Start date: 2019-06-25
Primary completion: 2022-09-19
Enrollment: 431

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.